Background/Objectives: Oxidative stress may induce insulin resistance in peripheral tissues and impair insulin secretion from pancreatic b-cells. Antioxidants are suggested to decrease the risk of diabetes through reduction of oxidative stress. However, only a few studies exist on dietary antioxidants and the risk of type 2 diabetes. We investigated the association of dietary antioxidants with incident type 2 diabetes in the a-Tocopherol, b-Carotene Cancer Prevention Study cohort. Subject/Methods: The study cohort included 29 133 male smokers aged 50-69 years. During a median follow-up of 10.2 years 660 incident cases of diabetes were observed among the 25 505 men with a completed baseline food frequency questionnaire. Results: Dietary a-tocopherol, b-tocopherol and b-tocotrienol were positively associated with the risk of diabetes when adjusted for age and supplementation (relative risk (RR) 1.17 (95% confidence interval (CI) 0.91-1.51) P for trend 0.02; RR 1.31 (95% CI 1.02-1.68) P for trend 0.01; RR 1.28 (95% CI 1.00-1.63) P for trend 0.01, respectively), but the association disappeared after multivariate adjustment (RR 0.92 (95% CI 0.71-1.19) P for trend 0.97; RR 1.06 (95% CI 0.82-1.36) P for trend 0.48; RR 1.04 (95% CI 0.80-1.35) P for trend 0.46, respectively). Other tocopherols and tocotrienols as well as vitamin C, carotenoids, flavonols and flavones had no association with risk of diabetes. Conclusions: Dietary antioxidants were not associated with a decreased risk of incident diabetes in middle-aged male smokers.
Introduction
Onset of type 2 diabetes is hypothesized to be genetically determined, but progression of diabetes is partly secondary due to hyperglycemia-induced generation of reactive oxygen species and inflammation damaging the pancreatic b-cells (Robertson et al., 2007) . A high degree of oxidative stress has also been postulated to be linked to decreased insulin responsiveness (Newsholme et al., 2007) .
Antioxidants have been proposed to prevent the development of type 2 diabetes (Ceriello and Motz, 2004; Rizzo et al., 2008) . In a meta-analysis, higher intakes of vitamin E and carotenoids, but not vitamin C and flavonoids were associated with a 25% reduction in type 2 diabetes risk, but the result for each antioxidant was based on only 2-3 studies with dissimilar risks (Hamer and Chida, 2007) .
Many mechanistic studies suggest the involvement of antioxidants in the development of type 2 diabetes (Dembinska-Kiec et al., 2008) . Supplemental vitamin E improved insulin sensitivity in healthy overweight subjects (Manning et al., 2004) . The combination of vitamins C, E and b-carotene moderately reduced insulin resistance during an 8-week supplementation in overweight young adults (Vincent et al., 2009) . However, controlled trials with high dosages of supplemental vitamin E and b-carotene have not shown decreased risk of type 2 diabetes (Liu et al., 1999 (Liu et al., , 2006 Lonn et al., 2002; Song et al., 2009) . Also in the a-Tocopherol, b-Carotene Cancer Prevention (ATBC) Study there was no effect on diabetes risk by a-tocopherol and b-carotene supplementation (Kataja-Tuomola et al., 2008) .
Because of the discrepancy in the associations of dietary antioxidant intake and risk of type 2 diabetes, we examined the association between dietary antioxidants (tocopherols, tocotrienols, vitamin C, carotenoids, flavonols and flavones) and risk of type 2 diabetes in the cohort of the ATBC Study.
Materials and methods

Participants
The ATBC Study was a randomized, double-blinded, placebocontrolled clinical trial undertaken to determine the effects of antioxidant supplements (a-tocopherol 50 mg daily, b-carotene 20 mg daily, both or placebo) on cancer among male smokers aged 50-69 years and living in Southwestern Finland (n ¼ 29 133) (ATBC Cancer Prevention Study Group, 1994) .
At baseline, men were excluded if they smoked fewer than five cigarettes a day, had a previous history of cancer, severe angina on exertion, chronic renal insufficiency, liver cirrhosis, alcoholism or other medical conditions limiting long-term participation. Furthermore, men who received anticoagulant therapy or used vitamin E, vitamin A or b-carotene supplements in excess of predefined doses were excluded.
The recruitment was carried out between 1985 and 1988, and the trial intervention continued until April 1993 with three follow-up visits annually. Thereafter, the trial cohort has been followed up through national registers. The Institutional Review Boards of the National Public Health Institute, Finland and the National Cancer Institute, USA approved the ATBC Study. All subjects provided their written, informed consent before randomization.
Ascertainment of diabetes
In Finland, patients requiring medical treatment for diabetes are entitled to reimbursement of their medication expenses according to the sickness insurance legislation. This requires a detailed medical certificate from the attending physician. The certificate of every case is verified to fulfill the diagnostic criteria for diabetes at the Social Insurance Institution of Finland, which maintains a central register of all persons receiving drug reimbursement. The ATBC Study participants were linked to the register through the unique personal identity number assigned to each Finnish citizen.
At baseline (1985) (1986) (1987) (1988) , 1272 participants had a history of diabetes diagnosed by a physician. Of the incident cases of diabetes diagnosed through December 1997, altogether 482 men were excluded due to high baseline concentration of serum glucose (X7.0 mmol/l). Furthermore, 1874 participants were excluded because of an incompletely filled food frequency questionnaire (FFQ). After the exclusions, the final cohort for this study comprised 25 505 men, among whom 660 incident cases of diabetes were identified from the drug reimbursement register through December 1997 (followed a median of 10.2 years).
Baseline data collection
At baseline, each subject completed questionnaires on general characteristics and medical history, smoking (cigarettes/day, smoking years) and physical activity (sedentary, moderate or heavy leisure-time activity). Height and weight were measured and body mass index (BMI, kg/m 2 ) was calculated. Blood pressure was measured using mercury sphygmomanometer (Rudolf Riester GmbH, Jungingen, Germany) of the right arm while the subject remained seated. Serum samples were collected and stored at À70 1C. Serum total cholesterol concentrations were determined enzymatically (CHOD-PAP method, Boehringer Mannheim, Mannheim, Germany). High-density lipoprotein cholesterol was measured after precipitation with dextran sulfate and magnesium chloride. Serum glucose was determined by the enzymatic hexokinase method using an Optima analyser (Thermo Fischer, Vantaa, Finland) .
Dietary assessment
Food consumption over the previous 12 months was assessed at baseline with a validated self-administered FFQ developed for the ATBC Study (Pietinen et al., 1988) . The consumption of 276 food items and mixed dishes was recorded by asking the number of times an item was usually consumed per day, week or month. Participants were also allowed to report additional foods consumed frequently, but not listed in the FFQ. The portion size was assessed by a picture booklet including 122 color photographs of food items or dishes. The participants completed the FFQ at home and returned it during the second baseline visit, when a trained study nurse checked the FFQ and elucidated discrepancies during a 30-min interview. Thereafter, a senior nutritionist reviewed all of the FFQs before final approval, 93% of the FFQs were approved.
The reproducibility and validity of the dietary questionnaire were tested in a pilot study with 189 men using a 24-day food record (2 Â 12 days) as a reference method (Pietinen et al., 1988) . The Spearman correlations between the FFQ and food records ranged from 0.59 to 0.68 for tocopherols, from 0.53 to 0.67 for tocotrienols, from 0.44 to 0.58 for carotenoids, from 0.46 to 0.66 for flavonoids and was 0.55 for vitamin C.
Daily nutrient intakes were calculated using the national food composition database of the National Institute for Health and Welfare. Vitamin E, vitamin C and carotenoid contents are based on Finnish analyses (Piironen, 1986; Heinonen, 1990) . Flavonol and flavone contents of foods are based mainly on composition analyses from the Netherlands (Hertog et al., 1992 (Hertog et al., , 1993 . The flavonol content of berries is, however, based on Finnish analyses (Häkkinen et al., 1999) .
The main dietary sources of tocopherols and tocotrienols among the ATBC participants were soft margarines, butter and eggs and of beta-carotene roots, vegetables and butter. For flavonoids the main dietary sources were tea (kaempferol), coffee (myricetin), roots (luteolin and apigenin) and vegetables (quercetin). Berries and fruits were also good sources of flavonoids. Potatoes, vegetables, fruits and berries were the main dietary sources for vitamin C.
Statistical analysis
The follow-up time extended from the date of randomization until entitlement of drug reimbursement for diabetes, death or end of follow-up (that is, December 1997), with a total of 244 877 person-years. The associations between quintiles of baseline intake of antioxidants and the incidence of diabetes were estimated by Cox proportional hazards regression and expressed as relative risk (RR) and its 95% confidence interval (CI). The intakes of antioxidants, protein and saturated fatty acids were adjusted for energy using a residual method (Willett and Stampfer, 1986) . The analyses were adjusted for supplementation group and age (model 1) and further in a multivariate model for BMI, number of daily cigarettes, years of smoking, serum total cholesterol and high-density lipoprotein cholesterol, systolic and diastolic blood pressure, alcohol intake, leisure-time physical activity and energy intake (model 2). The multivariate model was further adjusted for the other antioxidants in the same antioxidant group (tocopherols and tocotrienols, carotenoids, flavonols and flavones), for consumption of fruits, vegetables and berries and for consumption of coffee, protein and saturated fatty acids. The results of these additional models were similar to those of model 2, and thus, results from only model 2 are presented. Linearity of trend across quintiles was evaluated using Wald's test by treating the median value of each quintile as a continuous variable. The effect modifications of BMI, leisure-time physical activity and supplementation group were tested using the likelihood ratio test. All analyses were carried out with the R statistical program (R Development Core Team, 2009). All P-values were two-sided and Po0.05 was considered significant.
Baseline serum glucose was available for 496 non-cases. EM algorithm (Dempster et al., 1977) under the multivariate normal model was performed to impute missing serum glucose values for all non-cases. The imputation model included age, supplementation group, BMI, number of daily cigarettes, years of smoking, serum total cholesterol, highdensity lipoprotein cholesterol, systolic and diastolic blood pressure, alcohol intake, leisure-time physical activity, energy intake and serum glucose. Twenty sets of serum glucose values were imputated and the analyses were performed separately using each set. In each analysis men with baseline serum glucose X7 mmol/l were excluded. RR was estimated as average across each analysis. The results of these analyses were similar to those results when no exclusion was made among non-cases due to elevated serum glucose.
Results
Men who were diagnosed with incident diabetes were younger, had higher BMI, smoked more cigarettes daily, had higher blood pressure, but lower serum high-density lipoprotein cholesterol and participated in less leisure-time physical activity than non-cases (Table 1) .
Dietary a-tocopherol was positively associated with the risk of diabetes when adjusted for age and supplementation (P for trend 0.02) ( Table 2) . This association disappeared, however, after multivariate adjustment (RR 0.92, 95% CI 0.71-1.19 for the highest intake quintile vs the lowest, P for trend 0.97). Similarly, intakes of b-tocopherol and b-tocotrienol were associated with diabetes when adjusted for age and supplementation, but not after multivariate adjustment. Other tocopherols or tocotrienols and dietary vitamin C had no association with risk of diabetes (Table 2) .
Dietary b-carotene was not associated with the risk of diabetes (multivariate RR 1.03, 95% CI 0.79-1.35 for the highest intake quintile vs the lowest, P for trend 0.74) ( Table 3 ). The intakes of other carotenoids were also not associated with diabetes risk. The intake of the main flavonoid, quercetin, showed no association with risk of diabetes (multivariate RR 1.06, 95% CI 0.83-1.35 for the highest intake quintile vs the lowest, P for trend 0.57) ( Table 4) . Nor did other flavonoids have any association with diabetes risk.
No essential changes were found in the associations of different antioxidants when the first 5 years of follow-up were excluded. BMI, leisure-time physical activity or supplementation group did not modify the association between antioxidants and risk of diabetes.
Discussion
In this cohort study of middle-aged male smokers, dietary antioxidants were not associated with the risk of type 2 diabetes. Our results are in line with previous prospective studies with follow-up times of up to 23 years, where no significant association was found between antioxidant intake and risk for type 2 diabetes (Ford, 2001 ; Knekt et al., Intake of antioxidants and diabetes risk MK Kataja-Tuomola et al In a Finnish cohort study among 4304 subjects, high dietary b-cryptoxanthin (P for trend o0.001) and vitamin E (P for trend 0.02), but not other carotenoids or vitamin C were associated with a reduced risk for diabetes (Montonen et al., 2004) . The recently published, relatively small Uppsala Longitudinal Study of Adult Men in Sweden found that high dietary intake of b-carotene was associated with the lower risk of diabetes when compared with low intake (Po0.05) (Arnlöv et al., 2009) .
Circulating levels of antioxidants may better reflect oxidative capacity than dietary intakes. However, findings of associations between blood antioxidant concentrations and diabetes risk have also been contradictory in longitudinal studies. Baseline plasma vitamin C concentration was inversely associated with diabetes risk in an European study over a 12-year follow-up (Harding et al., 2008) . In addition, baseline serum a-tocopherol concentration in a small Finnish study and plasma carotenoid level in the Epidemiology of Vascular Ageing Study were associated inversely with the risk of diabetes (Knekt et al., 1999;  Adjusted as continuous by age, supplementation, body mass index, cigarettes smoked daily, smoking years, blood pressure, total cholesterol, high-density lipoprotein cholesterol, leisure-time physical activity and daily intake of alcohol and energy. Akbaraly et al., 2008) . However, in an other Finnish study there was no association between baseline serum a-tocopherol or b-carotene concentrations and risk of incident type 2 diabetes (Reunanen et al., 1998) . Neither baseline serum a-tocopherol nor b-carotene concentrations were associated with decreased risk of type 2 diabetes in the ATBC Study cohort (Kataja-Tuomola et al., 2008) . Moreover, neither association emerged between baseline plasma carotenoids and the risk of type 2 diabetes in the Women's Health Study, nor was an association seen between baseline plasma a-tocopherol concentration and risk of type 2 diabetes in the Insulin Resistance and Atherosclerosis Study (Mayer-Davis et al., 2002; Wang et al., 2006b) .
Our study has certain strengths and limitations that should be noted. Strength of the study is the large number of incident cases of diabetes identified from a national register with strict criteria for diabetes diagnosis. The register, however, enrolls only cases whose diabetes is treated with drugs. Thus it excludes cases treated with diet only and of course also unidentified cases. We do not have data to estimate the number of these cases in our cohort. In a Finnish study screening diabetes with oral glucose tolerance test, 13.6% of men aged 55-64 years had prevalent diabetes based on WHO-99 criteria (Report of a WHO Consultation, 1999) and of these 44% were unaware of their diabetic condition (Ylihärsilä et al., 2005) . This study suggests that a fairly big number of our cohort members may have had unidentified diabetes at the end of follow-up. We, however, do not believe that this concealed significant associations.
The register provides no information about whether the diabetes is type 1 or type 2. In a Finnish survey, 96% of all diabetic subjects diagnosed after the age of 55 years had type 2 diabetes (Laakso and Pyörälä, 1985) . Participants of our study were 50-69 years of age at study entry, and thus the incident cases of diabetes represent primarily type 2 diabetes.
Furthermore, extensive baseline information about risk factors for diabetes allowed comprehensive adjustment for potential confounders. We, however, had no follow-up data on these factors. Especially cessation of smoking reduces oxidative stress and may confound the association between antioxidants and diabetes risk. During the trial period, that is, during the first 6 years of follow-up of this study, about 20% of the participants stopped smoking (The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group, 1994) . Adjusted as continuous by age, supplementation, body mass index, cigarettes smoked daily, smoking years, blood pressure, total cholesterol, high-density lipoprotein cholesterol, leisure-time physical activity and daily intake of alcohol and energy.
